Cleared Special

K031168 - MATRIX STRETCH RESISTANT DETACHABLE COIL

K031168 is an FDA 510(k) clearance for MATRIX STRETCH RESISTANT DETACHABLE COIL, manufactured by Boston Scientific, Target. The device is a Class 2 Neurology device with product code HCG cleared through the Special 510(k) pathway after a 30-day FDA review.

K031168 · Boston Scientific, Target · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
30d
Days
Class 2
Risk

K031168 is an FDA 510(k) clearance for the MATRIX STRETCH RESISTANT DETACHABLE COIL. Classified as Device, Neurovascular Embolization (product code HCG), Class II - Special Controls.

Submitted by Boston Scientific, Target (Fremont, US). The FDA issued a Cleared decision on May 14, 2003 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5950 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific, Target devices

FDA 510(k) Submission Details - K031168

510(k) Number K031168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2003
Decision Date May 14, 2003
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 148d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

HCG Device Classification - Class 2, Special Controls

Product Code HCG Device, Neurovascular Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCG Device, Neurovascular Embolization

All 155
Devices cleared under the same product code (HCG) and FDA review panel - the closest regulatory comparables to K031168.
GUGLIELMI DETACHABLE COIL (GDC)
K031049 · Boston Scientific, Target · Aug 2003
SAPPHIRE DETACHABLE COIL SYSTEM
K030392 · Micro Therapeutics, Inc. · Jul 2003
TRUFILL DCS ORBIT DETACHABLE COIL AND TRUFILL DCS SYRINGE, ALSO KNOWN AS THE TRUFILL DCS ORBIT DETACHABLE COIL SYSTEM
K030963 · Cordis Neurovascular, Inc. · Jun 2003
GDC STRETCH RESISTANT DETACHABLE COIL
K030475 · Boston Scientific, Target · Mar 2003
MICROPLEX COIL SYSTEM (MCS) AND HYDROCOIL EMBOLIC SYSTEM (HES) WITH THE HYDROLINK SYRINGE KIT
K022735 · MicroVention, Inc. · Sep 2002
CONTOUR SE MICROSPHERES
K022427 · Boston Scientific Corp · Aug 2002